Jasper Therapeutics (JSPR) Cash & Equivalents (2019 - 2026)
Jasper Therapeutics (JSPR) reported Cash & Equivalents of $7.31 million for Q2 2026, down 81.5% from $39.51 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Jasper Therapeutics posted Cash & Equivalents of $28.69 million, down 59.9% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $71.64 million in FY2024 (-17.6%), $86.89 million in FY2023 (+127.2%), $38.25 million in FY2022 (-54.8%) and $84.7 million in FY2021 (+327.0%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q2 2021.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2021 (growth of 327.0%); the low point was Q2 2026 (a decline of 81.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Jasper Therapeutics | 14.04 Mn | -112.38 Mn | - | 7.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.31 Mn |
| Dec 31, 2025 | 28.69 Mn |
| Sep 30, 2025 | 50.90 Mn |
| Jun 30, 2025 | 39.51 Mn |
| Mar 31, 2025 | 48.80 Mn |
| Dec 31, 2024 | 71.64 Mn |
| Sep 30, 2024 | 92.50 Mn |
| Jun 30, 2024 | 106.82 Mn |
| Mar 31, 2024 | 118.50 Mn |
| Dec 31, 2023 | 86.89 Mn |
| Sep 30, 2023 | 103.90 Mn |
| Jun 30, 2023 | 115.81 Mn |
| Mar 31, 2023 | 129.40 Mn |
| Dec 31, 2022 | 38.25 Mn |
| Sep 30, 2022 | 50.95 Mn |
| Jun 30, 2022 | 60.81 Mn |
| Mar 31, 2022 | 70.40 Mn |
| Dec 31, 2021 | 84.70 Mn |
| Sep 30, 2021 | 100.91 Mn |
| Jun 30, 2021 | 309,730.00 |
API Access
Jasper Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();